| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INSERM Unit 36, Vascular Pathology and Renal Endocrinology, Collège de France 75005 Paris, France
Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS 91190 Gif-Sur-Yvette, France
Address requests for reprints to: Dr. E. Clauser, INSERM U36, Collège de France, 3, rue d'Ulm, 75005 Paris, France.
Abstract
The mas oncogene codes for a GTP binding proteincoupled receptor that determines a physiological response to angiotensin when expressed in Xenopus laevis oocytes or in the neuronal cell line NG115–401L. However, another gene, rat thoracic aorta gene, structurally related to mas, is devoid of any functional similarity with the angiotensin receptor(s). The relationships between the mas-related proteins and the angiotensin receptors were investigated by identifying and characterizing new members of the mas gene family. A new mas-related gene (mrg) was cloned in a human genomic library at low stringency using the mas cDNA as probe. Mrg codes for a seven-hydrophobic-segment receptor that is 35% identical to the mas product and 29% identical to the rat thoracic aorta gene product.
Mrg mRNA was not detected in several rat and human adult tissues that normally express the angiotensin II (All) receptor, and transfections of COS and CHO cells with the mrg gene did not modify the number of All binding sites. These results indicate that mrg and the human All receptor genes are not identical. However, injection of mrg mRNA into Xenopus oocytes markedly increased the electrophysiological response to angiotensin peptides, indicating some functional similarities with the mas product. The reduction of the response after defolliculation of the oocyte, together with the full agonist effect of Sar1lle8AII and the partial agonist effect of Sar1Ala8AII, seem to indicate that mrg interacts with the signaling pathways of the endogenous Xenopus angiotensin receptor to potentiate the response to All.
FOOTNOTES
This work was supported in part by a grant from CIBAGEIGY (Basel, Switzerland).
Received for publication May 24, 1991. Revision received July 19, 1991. Accepted for publication July 26, 1991.
This article has been cited by other articles:
![]() |
N. Alenina, P. Xu, B. Rentzsch, E. L. Patkin, and M. Bader Genetically altered animal models for Mas and angiotensin-(1-7) Exp Physiol, May 1, 2008; 93(5): 528 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Zylka, X. Dong, A. L. Southwell, and D. J. Anderson Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family PNAS, August 19, 2003; 100(17): 10043 - 10048. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gonzalez, D. L. Epstein, and T. Borrás Characterization of Gene Expression in Human Trabecular Meshwork Using Single-Pass Sequencing of 1060 Clones Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3678 - 3693. [Abstract] [Full Text] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. B. U. Halbach, T. Walther, M. Bader, and D. Albrecht Interaction Between Mas and the Angiotensin AT1 Receptor in the Amygdala J Neurophysiol, April 1, 2000; 83(4): 2012 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, D. Balschun, J.-P. Voigt, H. Fink, W. Zuschratter, C. Birchmeier, D. Ganten, and M. Bader Sustained Long Term Potentiation and Anxiety in Mice Lacking the Mas Protooncogene J. Biol. Chem., May 8, 1998; 273(19): 11867 - 11873. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |